A lentiviral vector-based insertional mutagenesis screen identifies mechanisms of resistance to MAPK inhibitors in melanoma

Pigment Cell Melanoma Res. 2019 Mar;32(2):332-335. doi: 10.1111/pcmr.12737. Epub 2018 Oct 19.

Marco Ranzani¹, Constantine Alifrangis^{2

3}, Nicola A Thompson¹, Alistair G Rust^{1

4}, Amin Allahyar⁵, Vivek Iyer¹, Stacey Price², Peter Ellis⁶, Gemma Turner¹, Jeroen de Ridder^{5

7}, Ultan McDermott², David J Adams¹

¹ Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
² Cancer Genome Project, The Wellcome Trust Sanger Institute, Hinxton, UK.
³ Division of Cancer, University College London Hospital, London, UK.
⁴ Tumour Profiling Unit, The Institute of Cancer Research, Chester Beatty Laboratories, London, UK.
⁵ Delft Bioinformatics Lab, TU Delft, Delft, The Netherlands.
⁶ Sequencing R&D, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
⁷ Centre for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

No abstract available

Publication types